New shot aims to shrink Hard-to-Treat blood cancers
NCT ID NCT07574346
First seen May 08, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This early study tests an injection called IASO207 in 18 adults with B-cell blood cancers (like lymphoma) that returned or didn't respond to prior treatments. The main goals are to check safety and find the right dose, while also seeing if tumors shrink. It's a first step to see if this approach is promising enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.